These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 2142394)

  • 61. Steroid receptors and progestinic therapy in ovarian endometrioid carcinoma.
    Rendina GM; Donadio C; Giovannini M
    Eur J Gynaecol Oncol; 1982; 3(3):241-6. PubMed ID: 6220903
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Estradiol and progesterone receptors in two cases of endometrial stromal sarcoma.
    Lantta M; Kahanpää K; Kärkkäinen J; Lehtovirta P; Wahlström T; Widholm O
    Gynecol Oncol; 1984 Jun; 18(2):233-9. PubMed ID: 6735266
    [TBL] [Abstract][Full Text] [Related]  

  • 63. [Borderline lesions in the endometrium].
    Kuramoto H; Kawaguchi M; Jobo T; Arai T
    Nihon Rinsho; 2004 Oct; 62 Suppl 10():279-84. PubMed ID: 15535251
    [No Abstract]   [Full Text] [Related]  

  • 64. Plasminogen activator activity in human endometrial carcinoma.
    Whitney CW; Satyaswaroop PG; Mortel R
    Gynecol Oncol; 1985 Sep; 22(1):97-104. PubMed ID: 3160638
    [TBL] [Abstract][Full Text] [Related]  

  • 65. The effects of medroxyprogesterone acetate on enzyme activities in human endometrial carcinoma.
    Philipson KA; Elder MG; White JO
    J Steroid Biochem; 1985 Dec; 23(6A):1059-64. PubMed ID: 2936931
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Endolymphatic stromal myosis: surgical and hormonal therapy for extensive venous recurrence.
    Montag TW; Manart FD
    Gynecol Oncol; 1989 May; 33(2):255-60. PubMed ID: 2539319
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Medroxyprogesterone acetate binding sites in human endometrium and endometrial cancer.
    Ohno Y; Fujibayashi H; Kitagawa I; Fujimoto Y; Okada H
    Gynecol Obstet Invest; 1990; 29(3):227-31. PubMed ID: 2141586
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Comparison of mass spectrometry and radioimmunoassay to measure medroxyprogesterone acetate in patients with endometrial cancer.
    Kärkkäinen J; Vesterinen E; Stenman UH; Adlercreutz H; Nieminen U; Widholm O
    Eur J Cancer; 1990; 26(9):975-7. PubMed ID: 2149024
    [TBL] [Abstract][Full Text] [Related]  

  • 69. The use of epostane in an attempt to reproduce cystic endometrial hyperplasia in the bitch.
    De Bosschere H; Ducatelle R; Tshamala M; Coryn M
    Vet Res Commun; 2003 Oct; 27(7):527-38. PubMed ID: 14609264
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Adjuvant medroxyprogesterone acetate and steroid hormone receptors in category M0 renal cell carcinoma. An interim report of a prospective randomized study.
    Pizzocaro G; Piva L; Salvioni R; Di Fronzo G; Ronchi E; Miodini P
    J Urol; 1986 Jan; 135(1):18-21. PubMed ID: 2934557
    [TBL] [Abstract][Full Text] [Related]  

  • 71. [Features of the endometrial steroid receptor system in habitual abortion with high risk of infectious complications].
    Demidova EM; Alekseeva ML; Novikov EA; Ezhova LS; Ankirskaia AS; Zemlianaia AA
    Akush Ginekol (Mosk); 1991 Sep; (9):10-2. PubMed ID: 1746687
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Determination of hormonal response in uterine cancer cell lines by the ATP bioluminescence assay and flow cytometry.
    Nguyen HN; Sevin BU; Averette HE; Voigt W; Perras J; Angioli R; Ramos R; Donato D; Penalver M
    Gynecol Oncol; 1992 Jul; 46(1):55-61. PubMed ID: 1386055
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Effects of high dose medroxyprogesterone acetate treatment on antithrombin III and other plasma proteins in males with renal cell or prostatic carcinoma.
    Nilsson TK; Tomic R; Ljungberg B
    Scand J Urol Nephrol; 1989; 23(1):11-4. PubMed ID: 2522237
    [TBL] [Abstract][Full Text] [Related]  

  • 74. [A case of endometriosis with massive ascites].
    Hattori S; Tamakoshi K; Oguchi H; Kodama H
    Nihon Sanka Fujinka Gakkai Zasshi; 1990 Mar; 42(3):291-4. PubMed ID: 2139691
    [No Abstract]   [Full Text] [Related]  

  • 75. Medroxyprogesterone acetate does not perturb the profile of steroid metabolites in urine during pregnancy.
    Yovich JL; Willcox DL; Wilkinson SP; Poletti VM; Hähnel R
    J Endocrinol; 1985 Mar; 104(3):453-9. PubMed ID: 3156203
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Adjunctive medroxyprogesterone acetate to radical nephrectomy in category M0 renal cell carcinoma. Preliminary report of a prospective randomized trial.
    Pizzocaro G; Di Fronzo G; Piva L; Salvioni R; Ronchi E; Cappelletti V; Giongo A; Mastroberardino E; Cozzoli C; Dormia E; Minervini S; Zanollo A; Fontanella U; Giannoni R; Maggioni A; Lasio E
    Eur Urol; 1983; 9(4):202-6. PubMed ID: 6223819
    [TBL] [Abstract][Full Text] [Related]  

  • 77. [Effect of progestin therapy on the level of cytoplasmic receptors in patients with cancer of the corpus uteri].
    Vishnevskiĭ AS; Bokhman IaV; Tsyrlina EV; Bobrov IuF; Fel'dkoren BI
    Vopr Onkol; 1989; 35(5):594-8. PubMed ID: 2545046
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Estrogen replacement therapy and endometrial hyperplasia.
    Tsang P
    JAMA; 1996 Jun; 275(24):1880-1. PubMed ID: 8648861
    [No Abstract]   [Full Text] [Related]  

  • 79. Hormone treatment and sex steroid receptors in metastatic renal cell carcinoma: report of a multicentric prospective study.
    Pizzocaro G; Di Fronzo G; Cappelletti V; Piva L; Salvioni R; Ronchi E; Giongo A; Dormia E; Zanollo A; Giannoni R; Maffeis V; Lasio E
    Tumori; 1983 Jun; 69(3):215-20. PubMed ID: 6306886
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Estrogen and progestogen therapy in advanced ovarian cancer: preliminary report.
    Jolles CJ; Freedman RS; Jones LA
    Gynecol Oncol; 1983 Dec; 16(3):352-9. PubMed ID: 6654179
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.